A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

Understanding patient personas could lead to better treatment adherence, experiences, and outcomes

by Dr. Bruce Green, managing director and chief medical officer, federal practice, Deloitte Consulting LLP; and Jessica Nadler, senior manager, Deloitte Consulting LLP

Understanding patient attitudes and preferences within the context of the patient journey can be central to supporting healthy behaviors and better health outcomes. To improve treatment adherence, health systems and clinicians should know their patient populations beyond demographic and disease information. They should consider getting to know what drives patient decision-making.

Patients are more than their disease—they are people with families and jobs,

Read more

From center ice to the operating room: AR/VR technologies could transform consumer, clinician, and patient experiences

by Shantaram (Shaun) Rangappa, MD, MSHA, Managing Director, Deloitte Consulting LLP

I live outside of Washington, D.C., and I was thrilled to see the Washington Capitals advance to the Stanley Cup finals for the first time in 20 years. I always enjoy watching sports on TV, but the experience has changed little since sports became televised. Now imagine donning an immersive experience headset and watching a championship game from center ice…with players gliding all around you.

Read more

Blockchain could help improve physician directories, but trust among health plans likely must come first

by Bobby Vaitla, Senior Manager, Deloitte Consulting LLP

The health care industry spends an estimated $2.1 billion a year to maintain physician data.1 Despite this substantial annual investment, physician directories are often inaccurate.

Some health plans are exploring blockchain as a possible technology that could solve this problem. While I agree that blockchain holds tremendous potential to improve the accuracy of directory data,

Read more

Hospitals look to strengthen the supply chain by producing some generics

by Swati Patel, PharmD, Specialist Leader, Deloitte Consulting LLP

In the late 1920s, Henry Ford owned rubber plants, coal mines, and iron-ore mines to guard against shortages from suppliers. He wanted to ensure that his manufacturing plants always had the raw materials needed to build cars.1

Similarly, some hospitals are looking into producing certain generic drugs to protect against shortages from suppliers that lead to postponed or canceled surgeries.

Read more

Technology and culture could expand roles for women working in hospitals

by Terri Cooper, PhD, Principal, Global Health Care Sector Leader, Deloitte Consulting LLP

Health care is an exciting and dynamic field—it is why I’ve been focused on it my entire career. The health care sector is on the cusp of incredible change, where everyone from executives to hourly employees could be impacted. This transition will likely be driven by two emerging, but powerful forces:

  • Inclusion: In an inclusive environment,
Read more

Beyond bitcoin: Five possible uses for blockchain in health care

by Greg Reh, Vice Chairman, US and Global Life Sciences Leader, Deloitte LLP

When I bring up blockchain in client meetings, or in dinner conversations, people tend to have one of two reactions. Either they see it as being synonymous with bitcoin and other digital currencies, or they see blockchain as an overhyped technology.

I agree there is a lot of hype swirling around blockchain, and I also agree that this technology likely isn’t going to turn health care on its head.

Read more